MetaCap

Who Owns Kazia Therapeutics Stock?

NASDAQ: KZIAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.93+0.11 (+1.25%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
31.70%
Institutional holders
41
  • Institutions 31.7%
  • Insiders 15.4%
  • Public and other 52.9%

Who owns Kazia Therapeutics stock?

Institutional investors own about 31.7% of Kazia Therapeutics's shares, spread across 41 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 15.42% of KZIA.

The largest institutional holders are Boxer Capital Management, LLC (4.32%), FLPutnam Investment Management Company (3.20%) and Bleichroeder LP (3.08%). Together, the top 10 institutions control 22.9% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their KZIA positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of KZIA

Kazia Therapeutics top institutional holders
InstitutionShares% HeldChange
Boxer Capital Management, LLC560.00K4.32%+100.0%
FLPutnam Investment Management Company414.96K3.20%+191.3%
Bleichroeder LP400.00K3.08%0.0%
Ikarian Capital, LLC396.20K3.06%+100.0%
Dauntless Investment Group, LLC 354.21K2.73%+343.7%
Stonepine Capital Management, LLC345.18K2.66%0.0%
Point72 Asset Management, L.P.200.30K1.54%+0.1%
Ensign Peak Advisors, Inc110.78K0.85%+100.0%
Millennium Management Llc101.38K0.78%+100.0%
UBS Group AG81.09K0.63%+482.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of KZIA

Kazia Therapeutics top fund holders
FundShares% Held
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund4.24K0.03%
Trust for Professional Managers-ActivePassive International Equity ETF3.25K0.03%

Frequently asked questions

Who is the largest shareholder of Kazia Therapeutics?

Boxer Capital Management, LLC is the largest institutional shareholder of KZIA, owning 4.32% of shares outstanding (560.00K shares) as of its latest 13F filing.

What percentage of Kazia Therapeutics is owned by institutions?

Institutions own about 31.7% of KZIA shares and 37.5% of the public float.

How much of Kazia Therapeutics do insiders own?

Insiders, such as officers and directors, own about 15.42% of KZIA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related